Disease activity in patients with multiple sclerosis treated with alemtuzumab due to a pregnancy desire

被引:0
|
作者
Tagliani, P. [1 ]
Vidal-Jordana, A. [2 ]
Zabalza, A. [2 ]
Arrambide, G. [2 ]
Rodriguez-Acevedo, B. [2 ]
Rio, J. [2 ]
Galan, I. [2 ]
Castillo, J. [3 ]
Midaglia, L. [4 ]
Cobo Calvo, A. [2 ]
Comabella, M. [2 ]
Nos, C. [2 ]
Auger, C. [5 ]
Rovira, A. [5 ]
Sastre-Garriga, J. [5 ]
Tintore, M. [2 ]
机构
[1] Vall dHebron Inst Recerca, Barcelona, Spain
[2] Vall dHebron Univ Campus, Dept Neurol Neuroimmunol, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona, Spain
[3] Neuroimmunol & Multiple Sclerosis Unit Girona, Girona, Spain
[4] Vall Hebron Univ Hosp, Multiple Sclerosis Ctr Catalonia Cemcat, Dept Neurol Neuroimmunol, Barcelona, Spain
[5] Vall Hebron Univ Hosp, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1119
引用
收藏
页码:647 / 647
页数:1
相关论文
共 50 条
  • [21] Long-term clinical outcomes of alemtuzumab in Korean patients with multiple sclerosis and predictor of disease activity despite alemtuzumab treatment
    Lee, Min Young
    Jang, Hyun-Min
    Park, Na Young
    Hyun, Jae-Won
    Kim, Su-Hyun
    Kim, Ho Jin
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP61 - NP62
  • [22] Biomarkers of disease activity in multiple sclerosis patients treated with immunomodulatory agents
    Hesse, Dan
    Krakauer, Martin
    Lund, Henrik
    Langkilde, Annika
    Sellebjerg, Finn
    Sorensen, Per Soelberg
    MULTIPLE SCLEROSIS, 2008, 14 : S281 - S281
  • [23] Real clinical experience in multiple sclerosis patients treated with alemtuzumab in the Northwest of Spain
    Lopez Real, A. M.
    Pena Martinez, J.
    Rodriguez Regal, A.
    Oterino Duran, A.
    Solar Sanchez, D. M.
    Pato Pato, A.
    Gonzalez Suarez, I.
    Garcia-Pelayo Rodriguez, A.
    Costa Arpin, E.
    Llaneza Gonzalez, M. A.
    Garcia Bargo, M. D.
    Rodriguez Rodriguez, M.
    Prieto Gonzalez, J. M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 851 - 852
  • [24] Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations
    Virginia Devonshire
    Richard Phillips
    Hilary Wass
    Gerald Da Roza
    Peter Senior
    Journal of Neurology, 2018, 265 : 2494 - 2505
  • [25] Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations
    Devonshire, Virginia
    Phillips, Richard
    Wass, Hilary
    Da Roza, Gerald
    Senior, Peter
    JOURNAL OF NEUROLOGY, 2018, 265 (11) : 2494 - 2505
  • [26] A case of acute fulminant multiple sclerosis treated with alemtuzumab
    Gobbin, F.
    Marangi, A.
    Orlandi, R.
    Richelli, S.
    Turatti, M.
    Calabrese, M.
    Forgion, A.
    Alessandrini, F.
    Benedetti, M. D.
    Monaco, S.
    Gajofatto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 941 - 942
  • [27] Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab
    Button, Tom
    Altmann, Dan
    Tozer, Dan
    Dalton, Catherine
    Hunter, Kelvin
    Compston, Alastair
    Coles, Alasdair
    Miller, David
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (02) : 241 - 244
  • [28] A case of acute fulminant multiple sclerosis treated with alemtuzumab
    Gobbin, F.
    Marangi, A.
    Orlandi, R.
    Richelli, S.
    Turatti, M.
    Calabrese, M.
    Forgione, A.
    Alessandrini, F.
    Benedetti, M. D.
    Monaco, S.
    Gajofatto, A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 17 : 9 - 11
  • [29] Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis
    Wehrum, Thomas
    Beume, Lena-Alexandra
    Stich, Oliver
    Mader, Irina
    Maeurer, Mathias
    Czaplinski, Adam
    Weiller, Cornelius
    Rauer, Sebastian
    NEUROLOGY, 2018, 90 (07) : E601 - E605
  • [30] Assessment of clinical disease activity and disability improvement by number-needed-to-treat analyses in patients with relapsing multiple sclerosis treated with alemtuzumab or ocrelizumab
    Alroughani, Raed
    Comi, Giancarlo
    Berkovich, Regina
    Izquierdo, Guillermo
    Kantor, Daniel
    LaGanke, Christopher
    Limmroth, Volker
    Macdonell, Richard A. L.
    Sharrack, Basil
    Wiendl, Heinz
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP11 - NP12